Global Omalizumab Monoclonal Antibody Biosimilars Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
Omalizumab monoclonal antibody biosimilar is a medication used to treat asthma, nasal polyps, and urticaria. Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes. Unlike an ordinary anti-IgE antibody, it does not bind to IgE that is already bound by the high affinity IgE receptor (Fc?RI) on the surface of mast cells, basophils, and antigen-presenting dendritic cells.
The global market for Omalizumab Monoclonal Antibody Biosimilars is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Omalizumab Monoclonal Antibody Biosimilars market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Omalizumab Monoclonal Antibody Biosimilars market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Omalizumab Monoclonal Antibody Biosimilars market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Omalizumab Monoclonal Antibody Biosimilars market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Omalizumab Monoclonal Antibody Biosimilars players cover Roche, Novartis, Glenmark Pharmaceuticals, Selexis and Generium, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Omalizumab Monoclonal Antibody Biosimilars market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Omalizumab Monoclonal Antibody Biosimilars market, with both quantitative and qualitative data, to help readers understand how the Omalizumab Monoclonal Antibody Biosimilars market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Units.
Market Segmentation:
The study segments the Omalizumab Monoclonal Antibody Biosimilars market and forecasts the market size by Type (150 mg/mL and 75 mg/0.5 mL,), by Application (Persistent Asthma, Nasal Polyps and Chronic Idiopathic Urticaria,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Omalizumab Monoclonal Antibody Biosimilars, Research Methodology, etc.
Chapter 2: Executive Summary, global Omalizumab Monoclonal Antibody Biosimilars market size (sales and revenue) and CAGR, Omalizumab Monoclonal Antibody Biosimilars market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Omalizumab Monoclonal Antibody Biosimilars sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Omalizumab Monoclonal Antibody Biosimilars sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Omalizumab Monoclonal Antibody Biosimilars market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Roche, Novartis, Glenmark Pharmaceuticals, Selexis, Generium, CuraTeQ, Celltrion Healthcare, Alvotech and BiosanaPharma, etc.
Chapter 14: Research Findings and Conclusion
Omalizumab monoclonal antibody biosimilar is a medication used to treat asthma, nasal polyps, and urticaria. Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes. Unlike an ordinary anti-IgE antibody, it does not bind to IgE that is already bound by the high affinity IgE receptor (Fc?RI) on the surface of mast cells, basophils, and antigen-presenting dendritic cells.
The global market for Omalizumab Monoclonal Antibody Biosimilars is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Omalizumab Monoclonal Antibody Biosimilars market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Omalizumab Monoclonal Antibody Biosimilars market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Omalizumab Monoclonal Antibody Biosimilars market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Omalizumab Monoclonal Antibody Biosimilars market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Omalizumab Monoclonal Antibody Biosimilars players cover Roche, Novartis, Glenmark Pharmaceuticals, Selexis and Generium, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Omalizumab Monoclonal Antibody Biosimilars market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Omalizumab Monoclonal Antibody Biosimilars market, with both quantitative and qualitative data, to help readers understand how the Omalizumab Monoclonal Antibody Biosimilars market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Units.
Market Segmentation:
The study segments the Omalizumab Monoclonal Antibody Biosimilars market and forecasts the market size by Type (150 mg/mL and 75 mg/0.5 mL,), by Application (Persistent Asthma, Nasal Polyps and Chronic Idiopathic Urticaria,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- 150 mg/mL
- 75 mg/0.5 mL
- Persistent Asthma
- Nasal Polyps
- Chronic Idiopathic Urticaria
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Novartis
- Glenmark Pharmaceuticals
- Selexis
- Generium
- CuraTeQ
- Celltrion Healthcare
- Alvotech
- BiosanaPharma
- Mabpharm
- CSPC Pharmaceutical Group
- Biomabs
- HisunPharm
- Grand Pharm
Chapter 1: Scope of Omalizumab Monoclonal Antibody Biosimilars, Research Methodology, etc.
Chapter 2: Executive Summary, global Omalizumab Monoclonal Antibody Biosimilars market size (sales and revenue) and CAGR, Omalizumab Monoclonal Antibody Biosimilars market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Omalizumab Monoclonal Antibody Biosimilars sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Omalizumab Monoclonal Antibody Biosimilars sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Omalizumab Monoclonal Antibody Biosimilars market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Roche, Novartis, Glenmark Pharmaceuticals, Selexis, Generium, CuraTeQ, Celltrion Healthcare, Alvotech and BiosanaPharma, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Omalizumab Monoclonal Antibody Biosimilars Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Omalizumab Monoclonal Antibody Biosimilars by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Omalizumab Monoclonal Antibody Biosimilars by Country/Region, 2017, 2022 & 2028
2.2 Omalizumab Monoclonal Antibody Biosimilars Segment by Type
2.2.1 150 mg/mL
2.2.2 75 mg/0.5 mL
2.3 Omalizumab Monoclonal Antibody Biosimilars Sales by Type
2.3.1 Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
2.3.2 Global Omalizumab Monoclonal Antibody Biosimilars Revenue and Market Share by Type (2017-2022)
2.3.3 Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Type (2017-2022)
2.4 Omalizumab Monoclonal Antibody Biosimilars Segment by Application
2.4.1 Persistent Asthma
2.4.2 Nasal Polyps
2.4.3 Chronic Idiopathic Urticaria
2.5 Omalizumab Monoclonal Antibody Biosimilars Sales by Application
2.5.1 Global Omalizumab Monoclonal Antibody Biosimilars Sale Market Share by Application (2017-2022)
2.5.2 Global Omalizumab Monoclonal Antibody Biosimilars Revenue and Market Share by Application (2017-2022)
2.5.3 Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Application (2017-2022)
3 GLOBAL OMALIZUMAB MONOCLONAL ANTIBODY BIOSIMILARS BY COMPANY
3.1 Global Omalizumab Monoclonal Antibody Biosimilars Breakdown Data by Company
3.1.1 Global Omalizumab Monoclonal Antibody Biosimilars Annual Sales by Company (2020-2022)
3.1.2 Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Company (2020-2022)
3.2 Global Omalizumab Monoclonal Antibody Biosimilars Annual Revenue by Company (2020-2022)
3.2.1 Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Company (2020-2022)
3.2.2 Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Company (2020-2022)
3.3 Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Company
3.4 Key Manufacturers Omalizumab Monoclonal Antibody Biosimilars Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Omalizumab Monoclonal Antibody Biosimilars Product Location Distribution
3.4.2 Players Omalizumab Monoclonal Antibody Biosimilars Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OMALIZUMAB MONOCLONAL ANTIBODY BIOSIMILARS BY GEOGRAPHIC REGION
4.1 World Historic Omalizumab Monoclonal Antibody Biosimilars Market Size by Geographic Region (2017-2022)
4.1.1 Global Omalizumab Monoclonal Antibody Biosimilars Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Omalizumab Monoclonal Antibody Biosimilars Annual Revenue by Geographic Region
4.2 World Historic Omalizumab Monoclonal Antibody Biosimilars Market Size by Country/Region (2017-2022)
4.2.1 Global Omalizumab Monoclonal Antibody Biosimilars Annual Sales by Country/Region (2017-2022)
4.2.2 Global Omalizumab Monoclonal Antibody Biosimilars Annual Revenue by Country/Region
4.3 Americas Omalizumab Monoclonal Antibody Biosimilars Sales Growth
4.4 APAC Omalizumab Monoclonal Antibody Biosimilars Sales Growth
4.5 Europe Omalizumab Monoclonal Antibody Biosimilars Sales Growth
4.6 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Growth
5 AMERICAS
5.1 Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Country
5.1.1 Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022)
5.1.2 Americas Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022)
5.2 Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Type
5.3 Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Region
6.1.1 APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Region (2017-2022)
6.1.2 APAC Omalizumab Monoclonal Antibody Biosimilars Revenue by Region (2017-2022)
6.2 APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Type
6.3 APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Omalizumab Monoclonal Antibody Biosimilars by Country
7.1.1 Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022)
7.1.2 Europe Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022)
7.2 Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Type
7.3 Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars by Country
8.1.1 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022)
8.1.2 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022)
8.2 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Type
8.3 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Omalizumab Monoclonal Antibody Biosimilars
10.3 Manufacturing Process Analysis of Omalizumab Monoclonal Antibody Biosimilars
10.4 Industry Chain Structure of Omalizumab Monoclonal Antibody Biosimilars
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Omalizumab Monoclonal Antibody Biosimilars Distributors
11.3 Omalizumab Monoclonal Antibody Biosimilars Customer
12 WORLD FORECAST REVIEW FOR OMALIZUMAB MONOCLONAL ANTIBODY BIOSIMILARS BY GEOGRAPHIC REGION
12.1 Global Omalizumab Monoclonal Antibody Biosimilars Market Size Forecast by Region
12.1.1 Global Omalizumab Monoclonal Antibody Biosimilars Forecast by Region (2023-2028)
12.1.2 Global Omalizumab Monoclonal Antibody Biosimilars Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Omalizumab Monoclonal Antibody Biosimilars Forecast by Type
12.7 Global Omalizumab Monoclonal Antibody Biosimilars Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.1.3 Roche Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.2.3 Novartis Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Glenmark Pharmaceuticals
13.3.1 Glenmark Pharmaceuticals Company Information
13.3.2 Glenmark Pharmaceuticals Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.3.3 Glenmark Pharmaceuticals Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Glenmark Pharmaceuticals Main Business Overview
13.3.5 Glenmark Pharmaceuticals Latest Developments
13.4 Selexis
13.4.1 Selexis Company Information
13.4.2 Selexis Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.4.3 Selexis Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Selexis Main Business Overview
13.4.5 Selexis Latest Developments
13.5 Generium
13.5.1 Generium Company Information
13.5.2 Generium Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.5.3 Generium Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Generium Main Business Overview
13.5.5 Generium Latest Developments
13.6 CuraTeQ
13.6.1 CuraTeQ Company Information
13.6.2 CuraTeQ Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.6.3 CuraTeQ Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 CuraTeQ Main Business Overview
13.6.5 CuraTeQ Latest Developments
13.7 Celltrion Healthcare
13.7.1 Celltrion Healthcare Company Information
13.7.2 Celltrion Healthcare Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.7.3 Celltrion Healthcare Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Celltrion Healthcare Main Business Overview
13.7.5 Celltrion Healthcare Latest Developments
13.8 Alvotech
13.8.1 Alvotech Company Information
13.8.2 Alvotech Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.8.3 Alvotech Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Alvotech Main Business Overview
13.8.5 Alvotech Latest Developments
13.9 BiosanaPharma
13.9.1 BiosanaPharma Company Information
13.9.2 BiosanaPharma Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.9.3 BiosanaPharma Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 BiosanaPharma Main Business Overview
13.9.5 BiosanaPharma Latest Developments
13.10 Mabpharm
13.10.1 Mabpharm Company Information
13.10.2 Mabpharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.10.3 Mabpharm Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Mabpharm Main Business Overview
13.10.5 Mabpharm Latest Developments
13.11 CSPC Pharmaceutical Group
13.11.1 CSPC Pharmaceutical Group Company Information
13.11.2 CSPC Pharmaceutical Group Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.11.3 CSPC Pharmaceutical Group Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 CSPC Pharmaceutical Group Main Business Overview
13.11.5 CSPC Pharmaceutical Group Latest Developments
13.12 Biomabs
13.12.1 Biomabs Company Information
13.12.2 Biomabs Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.12.3 Biomabs Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Biomabs Main Business Overview
13.12.5 Biomabs Latest Developments
13.13 HisunPharm
13.13.1 HisunPharm Company Information
13.13.2 HisunPharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.13.3 HisunPharm Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 HisunPharm Main Business Overview
13.13.5 HisunPharm Latest Developments
13.14 Grand Pharm
13.14.1 Grand Pharm Company Information
13.14.2 Grand Pharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.14.3 Grand Pharm Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Grand Pharm Main Business Overview
13.14.5 Grand Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Omalizumab Monoclonal Antibody Biosimilars Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Omalizumab Monoclonal Antibody Biosimilars by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Omalizumab Monoclonal Antibody Biosimilars by Country/Region, 2017, 2022 & 2028
2.2 Omalizumab Monoclonal Antibody Biosimilars Segment by Type
2.2.1 150 mg/mL
2.2.2 75 mg/0.5 mL
2.3 Omalizumab Monoclonal Antibody Biosimilars Sales by Type
2.3.1 Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
2.3.2 Global Omalizumab Monoclonal Antibody Biosimilars Revenue and Market Share by Type (2017-2022)
2.3.3 Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Type (2017-2022)
2.4 Omalizumab Monoclonal Antibody Biosimilars Segment by Application
2.4.1 Persistent Asthma
2.4.2 Nasal Polyps
2.4.3 Chronic Idiopathic Urticaria
2.5 Omalizumab Monoclonal Antibody Biosimilars Sales by Application
2.5.1 Global Omalizumab Monoclonal Antibody Biosimilars Sale Market Share by Application (2017-2022)
2.5.2 Global Omalizumab Monoclonal Antibody Biosimilars Revenue and Market Share by Application (2017-2022)
2.5.3 Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Application (2017-2022)
3 GLOBAL OMALIZUMAB MONOCLONAL ANTIBODY BIOSIMILARS BY COMPANY
3.1 Global Omalizumab Monoclonal Antibody Biosimilars Breakdown Data by Company
3.1.1 Global Omalizumab Monoclonal Antibody Biosimilars Annual Sales by Company (2020-2022)
3.1.2 Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Company (2020-2022)
3.2 Global Omalizumab Monoclonal Antibody Biosimilars Annual Revenue by Company (2020-2022)
3.2.1 Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Company (2020-2022)
3.2.2 Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Company (2020-2022)
3.3 Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Company
3.4 Key Manufacturers Omalizumab Monoclonal Antibody Biosimilars Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Omalizumab Monoclonal Antibody Biosimilars Product Location Distribution
3.4.2 Players Omalizumab Monoclonal Antibody Biosimilars Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OMALIZUMAB MONOCLONAL ANTIBODY BIOSIMILARS BY GEOGRAPHIC REGION
4.1 World Historic Omalizumab Monoclonal Antibody Biosimilars Market Size by Geographic Region (2017-2022)
4.1.1 Global Omalizumab Monoclonal Antibody Biosimilars Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Omalizumab Monoclonal Antibody Biosimilars Annual Revenue by Geographic Region
4.2 World Historic Omalizumab Monoclonal Antibody Biosimilars Market Size by Country/Region (2017-2022)
4.2.1 Global Omalizumab Monoclonal Antibody Biosimilars Annual Sales by Country/Region (2017-2022)
4.2.2 Global Omalizumab Monoclonal Antibody Biosimilars Annual Revenue by Country/Region
4.3 Americas Omalizumab Monoclonal Antibody Biosimilars Sales Growth
4.4 APAC Omalizumab Monoclonal Antibody Biosimilars Sales Growth
4.5 Europe Omalizumab Monoclonal Antibody Biosimilars Sales Growth
4.6 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Growth
5 AMERICAS
5.1 Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Country
5.1.1 Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022)
5.1.2 Americas Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022)
5.2 Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Type
5.3 Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Region
6.1.1 APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Region (2017-2022)
6.1.2 APAC Omalizumab Monoclonal Antibody Biosimilars Revenue by Region (2017-2022)
6.2 APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Type
6.3 APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Omalizumab Monoclonal Antibody Biosimilars by Country
7.1.1 Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022)
7.1.2 Europe Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022)
7.2 Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Type
7.3 Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars by Country
8.1.1 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022)
8.1.2 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022)
8.2 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Type
8.3 Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Omalizumab Monoclonal Antibody Biosimilars
10.3 Manufacturing Process Analysis of Omalizumab Monoclonal Antibody Biosimilars
10.4 Industry Chain Structure of Omalizumab Monoclonal Antibody Biosimilars
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Omalizumab Monoclonal Antibody Biosimilars Distributors
11.3 Omalizumab Monoclonal Antibody Biosimilars Customer
12 WORLD FORECAST REVIEW FOR OMALIZUMAB MONOCLONAL ANTIBODY BIOSIMILARS BY GEOGRAPHIC REGION
12.1 Global Omalizumab Monoclonal Antibody Biosimilars Market Size Forecast by Region
12.1.1 Global Omalizumab Monoclonal Antibody Biosimilars Forecast by Region (2023-2028)
12.1.2 Global Omalizumab Monoclonal Antibody Biosimilars Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Omalizumab Monoclonal Antibody Biosimilars Forecast by Type
12.7 Global Omalizumab Monoclonal Antibody Biosimilars Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.1.3 Roche Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.2.3 Novartis Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Glenmark Pharmaceuticals
13.3.1 Glenmark Pharmaceuticals Company Information
13.3.2 Glenmark Pharmaceuticals Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.3.3 Glenmark Pharmaceuticals Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Glenmark Pharmaceuticals Main Business Overview
13.3.5 Glenmark Pharmaceuticals Latest Developments
13.4 Selexis
13.4.1 Selexis Company Information
13.4.2 Selexis Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.4.3 Selexis Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Selexis Main Business Overview
13.4.5 Selexis Latest Developments
13.5 Generium
13.5.1 Generium Company Information
13.5.2 Generium Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.5.3 Generium Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Generium Main Business Overview
13.5.5 Generium Latest Developments
13.6 CuraTeQ
13.6.1 CuraTeQ Company Information
13.6.2 CuraTeQ Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.6.3 CuraTeQ Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 CuraTeQ Main Business Overview
13.6.5 CuraTeQ Latest Developments
13.7 Celltrion Healthcare
13.7.1 Celltrion Healthcare Company Information
13.7.2 Celltrion Healthcare Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.7.3 Celltrion Healthcare Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Celltrion Healthcare Main Business Overview
13.7.5 Celltrion Healthcare Latest Developments
13.8 Alvotech
13.8.1 Alvotech Company Information
13.8.2 Alvotech Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.8.3 Alvotech Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Alvotech Main Business Overview
13.8.5 Alvotech Latest Developments
13.9 BiosanaPharma
13.9.1 BiosanaPharma Company Information
13.9.2 BiosanaPharma Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.9.3 BiosanaPharma Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 BiosanaPharma Main Business Overview
13.9.5 BiosanaPharma Latest Developments
13.10 Mabpharm
13.10.1 Mabpharm Company Information
13.10.2 Mabpharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.10.3 Mabpharm Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Mabpharm Main Business Overview
13.10.5 Mabpharm Latest Developments
13.11 CSPC Pharmaceutical Group
13.11.1 CSPC Pharmaceutical Group Company Information
13.11.2 CSPC Pharmaceutical Group Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.11.3 CSPC Pharmaceutical Group Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 CSPC Pharmaceutical Group Main Business Overview
13.11.5 CSPC Pharmaceutical Group Latest Developments
13.12 Biomabs
13.12.1 Biomabs Company Information
13.12.2 Biomabs Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.12.3 Biomabs Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Biomabs Main Business Overview
13.12.5 Biomabs Latest Developments
13.13 HisunPharm
13.13.1 HisunPharm Company Information
13.13.2 HisunPharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.13.3 HisunPharm Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 HisunPharm Main Business Overview
13.13.5 HisunPharm Latest Developments
13.14 Grand Pharm
13.14.1 Grand Pharm Company Information
13.14.2 Grand Pharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
13.14.3 Grand Pharm Omalizumab Monoclonal Antibody Biosimilars Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Grand Pharm Main Business Overview
13.14.5 Grand Pharm Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Omalizumab Monoclonal Antibody Biosimilars Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Omalizumab Monoclonal Antibody Biosimilars Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 150 mg/mL
Table 4. Major Players of 75 mg/0.5 mL
Table 5. Global Omalizumab Monoclonal Antibody Biosimilars Sales by Type (2017-2022) & (Units)
Table 6. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
Table 7. Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Type (2017-2022) & ($ million)
Table 8. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Type (2017-2022)
Table 9. Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Omalizumab Monoclonal Antibody Biosimilars Sales by Application (2017-2022) & (Units)
Table 11. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Table 12. Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Application (2017-2022)
Table 13. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Application (2017-2022)
Table 14. Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Omalizumab Monoclonal Antibody Biosimilars Sales by Company (2020-2022) & (Units)
Table 16. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Company (2020-2022)
Table 17. Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Company (2020-2022)
Table 19. Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Omalizumab Monoclonal Antibody Biosimilars Producing Area Distribution and Sales Area
Table 21. Players Omalizumab Monoclonal Antibody Biosimilars Products Offered
Table 22. Omalizumab Monoclonal Antibody Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Omalizumab Monoclonal Antibody Biosimilars Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share Geographic Region (2017-2022)
Table 27. Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Omalizumab Monoclonal Antibody Biosimilars Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country/Region (2017-2022)
Table 31. Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022) & (Units)
Table 34. Americas Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country (2017-2022)
Table 35. Americas Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country (2017-2022)
Table 37. Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Type (2017-2022) & (Units)
Table 38. Americas Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
Table 39. Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Application (2017-2022) & (Units)
Table 40. Americas Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Table 41. APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Region (2017-2022) & (Units)
Table 42. APAC Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Region (2017-2022)
Table 43. APAC Omalizumab Monoclonal Antibody Biosimilars Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Region (2017-2022)
Table 45. APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Type (2017-2022) & (Units)
Table 46. APAC Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
Table 47. APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Application (2017-2022) & (Units)
Table 48. APAC Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Table 49. Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022) & (Units)
Table 50. Europe Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country (2017-2022)
Table 51. Europe Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country (2017-2022)
Table 53. Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Type (2017-2022) & (Units)
Table 54. Europe Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
Table 55. Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Application (2017-2022) & (Units)
Table 56. Europe Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Omalizumab Monoclonal Antibody Biosimilars
Table 66. Key Market Challenges & Risks of Omalizumab Monoclonal Antibody Biosimilars
Table 67. Key Industry Trends of Omalizumab Monoclonal Antibody Biosimilars
Table 68. Omalizumab Monoclonal Antibody Biosimilars Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Omalizumab Monoclonal Antibody Biosimilars Distributors List
Table 71. Omalizumab Monoclonal Antibody Biosimilars Customer List
Table 72. Global Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Forecast by Region
Table 74. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share Forecast by Application (2023-2028)
Table 92. Roche Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 93. Roche Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 94. Roche Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Roche Main Business
Table 96. Roche Latest Developments
Table 97. Novartis Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 99. Novartis Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Novartis Main Business
Table 101. Novartis Latest Developments
Table 102. Glenmark Pharmaceuticals Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 103. Glenmark Pharmaceuticals Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 104. Glenmark Pharmaceuticals Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Glenmark Pharmaceuticals Main Business
Table 106. Glenmark Pharmaceuticals Latest Developments
Table 107. Selexis Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 108. Selexis Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 109. Selexis Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Selexis Main Business
Table 111. Selexis Latest Developments
Table 112. Generium Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 113. Generium Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 114. Generium Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Generium Main Business
Table 116. Generium Latest Developments
Table 117. CuraTeQ Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 118. CuraTeQ Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 119. CuraTeQ Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. CuraTeQ Main Business
Table 121. CuraTeQ Latest Developments
Table 122. Celltrion Healthcare Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 123. Celltrion Healthcare Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 124. Celltrion Healthcare Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Celltrion Healthcare Main Business
Table 126. Celltrion Healthcare Latest Developments
Table 127. Alvotech Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 128. Alvotech Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 129. Alvotech Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Alvotech Main Business
Table 131. Alvotech Latest Developments
Table 132. BiosanaPharma Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 133. BiosanaPharma Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 134. BiosanaPharma Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. BiosanaPharma Main Business
Table 136. BiosanaPharma Latest Developments
Table 137. Mabpharm Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 138. Mabpharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 139. Mabpharm Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Mabpharm Main Business
Table 141. Mabpharm Latest Developments
Table 142. CSPC Pharmaceutical Group Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 143. CSPC Pharmaceutical Group Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 144. CSPC Pharmaceutical Group Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. CSPC Pharmaceutical Group Main Business
Table 146. CSPC Pharmaceutical Group Latest Developments
Table 147. Biomabs Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 148. Biomabs Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 149. Biomabs Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Biomabs Main Business
Table 151. Biomabs Latest Developments
Table 152. HisunPharm Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 153. HisunPharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 154. HisunPharm Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. HisunPharm Main Business
Table 156. HisunPharm Latest Developments
Table 157. Grand Pharm Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 158. Grand Pharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 159. Grand Pharm Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. Grand Pharm Main Business
Table 161. Grand Pharm Latest Developments
Table 1. Omalizumab Monoclonal Antibody Biosimilars Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Omalizumab Monoclonal Antibody Biosimilars Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 150 mg/mL
Table 4. Major Players of 75 mg/0.5 mL
Table 5. Global Omalizumab Monoclonal Antibody Biosimilars Sales by Type (2017-2022) & (Units)
Table 6. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
Table 7. Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Type (2017-2022) & ($ million)
Table 8. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Type (2017-2022)
Table 9. Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Omalizumab Monoclonal Antibody Biosimilars Sales by Application (2017-2022) & (Units)
Table 11. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Table 12. Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Application (2017-2022)
Table 13. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Application (2017-2022)
Table 14. Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Omalizumab Monoclonal Antibody Biosimilars Sales by Company (2020-2022) & (Units)
Table 16. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Company (2020-2022)
Table 17. Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Company (2020-2022)
Table 19. Global Omalizumab Monoclonal Antibody Biosimilars Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Omalizumab Monoclonal Antibody Biosimilars Producing Area Distribution and Sales Area
Table 21. Players Omalizumab Monoclonal Antibody Biosimilars Products Offered
Table 22. Omalizumab Monoclonal Antibody Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Omalizumab Monoclonal Antibody Biosimilars Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share Geographic Region (2017-2022)
Table 27. Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Omalizumab Monoclonal Antibody Biosimilars Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country/Region (2017-2022)
Table 31. Global Omalizumab Monoclonal Antibody Biosimilars Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022) & (Units)
Table 34. Americas Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country (2017-2022)
Table 35. Americas Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country (2017-2022)
Table 37. Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Type (2017-2022) & (Units)
Table 38. Americas Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
Table 39. Americas Omalizumab Monoclonal Antibody Biosimilars Sales by Application (2017-2022) & (Units)
Table 40. Americas Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Table 41. APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Region (2017-2022) & (Units)
Table 42. APAC Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Region (2017-2022)
Table 43. APAC Omalizumab Monoclonal Antibody Biosimilars Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Region (2017-2022)
Table 45. APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Type (2017-2022) & (Units)
Table 46. APAC Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
Table 47. APAC Omalizumab Monoclonal Antibody Biosimilars Sales by Application (2017-2022) & (Units)
Table 48. APAC Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Table 49. Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022) & (Units)
Table 50. Europe Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country (2017-2022)
Table 51. Europe Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country (2017-2022)
Table 53. Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Type (2017-2022) & (Units)
Table 54. Europe Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
Table 55. Europe Omalizumab Monoclonal Antibody Biosimilars Sales by Application (2017-2022) & (Units)
Table 56. Europe Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Omalizumab Monoclonal Antibody Biosimilars
Table 66. Key Market Challenges & Risks of Omalizumab Monoclonal Antibody Biosimilars
Table 67. Key Industry Trends of Omalizumab Monoclonal Antibody Biosimilars
Table 68. Omalizumab Monoclonal Antibody Biosimilars Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Omalizumab Monoclonal Antibody Biosimilars Distributors List
Table 71. Omalizumab Monoclonal Antibody Biosimilars Customer List
Table 72. Global Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Forecast by Region
Table 74. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Omalizumab Monoclonal Antibody Biosimilars Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share Forecast by Application (2023-2028)
Table 92. Roche Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 93. Roche Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 94. Roche Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Roche Main Business
Table 96. Roche Latest Developments
Table 97. Novartis Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 99. Novartis Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Novartis Main Business
Table 101. Novartis Latest Developments
Table 102. Glenmark Pharmaceuticals Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 103. Glenmark Pharmaceuticals Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 104. Glenmark Pharmaceuticals Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Glenmark Pharmaceuticals Main Business
Table 106. Glenmark Pharmaceuticals Latest Developments
Table 107. Selexis Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 108. Selexis Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 109. Selexis Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Selexis Main Business
Table 111. Selexis Latest Developments
Table 112. Generium Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 113. Generium Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 114. Generium Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Generium Main Business
Table 116. Generium Latest Developments
Table 117. CuraTeQ Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 118. CuraTeQ Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 119. CuraTeQ Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. CuraTeQ Main Business
Table 121. CuraTeQ Latest Developments
Table 122. Celltrion Healthcare Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 123. Celltrion Healthcare Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 124. Celltrion Healthcare Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Celltrion Healthcare Main Business
Table 126. Celltrion Healthcare Latest Developments
Table 127. Alvotech Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 128. Alvotech Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 129. Alvotech Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Alvotech Main Business
Table 131. Alvotech Latest Developments
Table 132. BiosanaPharma Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 133. BiosanaPharma Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 134. BiosanaPharma Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. BiosanaPharma Main Business
Table 136. BiosanaPharma Latest Developments
Table 137. Mabpharm Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 138. Mabpharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 139. Mabpharm Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Mabpharm Main Business
Table 141. Mabpharm Latest Developments
Table 142. CSPC Pharmaceutical Group Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 143. CSPC Pharmaceutical Group Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 144. CSPC Pharmaceutical Group Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. CSPC Pharmaceutical Group Main Business
Table 146. CSPC Pharmaceutical Group Latest Developments
Table 147. Biomabs Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 148. Biomabs Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 149. Biomabs Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Biomabs Main Business
Table 151. Biomabs Latest Developments
Table 152. HisunPharm Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 153. HisunPharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 154. HisunPharm Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. HisunPharm Main Business
Table 156. HisunPharm Latest Developments
Table 157. Grand Pharm Basic Information, Omalizumab Monoclonal Antibody Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 158. Grand Pharm Omalizumab Monoclonal Antibody Biosimilars Product Offered
Table 159. Grand Pharm Omalizumab Monoclonal Antibody Biosimilars Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. Grand Pharm Main Business
Table 161. Grand Pharm Latest Developments
LIST OF FIGURES
Figure 1. Picture of Omalizumab Monoclonal Antibody Biosimilars
Figure 2. Omalizumab Monoclonal Antibody Biosimilars Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Omalizumab Monoclonal Antibody Biosimilars Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Omalizumab Monoclonal Antibody Biosimilars Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 150 mg/mL
Figure 10. Product Picture of 75 mg/0.5 mL
Figure 11. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type in 2021
Figure 12. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Type (2017-2022)
Figure 13. Omalizumab Monoclonal Antibody Biosimilars Consumed in Persistent Asthma
Figure 14. Global Omalizumab Monoclonal Antibody Biosimilars Market: Persistent Asthma (2017-2022) & (Units)
Figure 15. Omalizumab Monoclonal Antibody Biosimilars Consumed in Nasal Polyps
Figure 16. Global Omalizumab Monoclonal Antibody Biosimilars Market: Nasal Polyps (2017-2022) & (Units)
Figure 17. Omalizumab Monoclonal Antibody Biosimilars Consumed in Chronic Idiopathic Urticaria
Figure 18. Global Omalizumab Monoclonal Antibody Biosimilars Market: Chronic Idiopathic Urticaria (2017-2022) & (Units)
Figure 19. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Figure 20. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Application in 2021
Figure 21. Omalizumab Monoclonal Antibody Biosimilars Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Company in 2021
Figure 23. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Geographic Region in 2021
Figure 25. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Region (2017-2022)
Figure 26. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country/Region in 2021
Figure 27. Americas Omalizumab Monoclonal Antibody Biosimilars Sales 2017-2022 (Units)
Figure 28. Americas Omalizumab Monoclonal Antibody Biosimilars Revenue 2017-2022 ($ Millions)
Figure 29. APAC Omalizumab Monoclonal Antibody Biosimilars Sales 2017-2022 (Units)
Figure 30. APAC Omalizumab Monoclonal Antibody Biosimilars Revenue 2017-2022 ($ Millions)
Figure 31. Europe Omalizumab Monoclonal Antibody Biosimilars Sales 2017-2022 (Units)
Figure 32. Europe Omalizumab Monoclonal Antibody Biosimilars Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales 2017-2022 (Units)
Figure 34. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue 2017-2022 ($ Millions)
Figure 35. Americas Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country in 2021
Figure 36. Americas Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country in 2021
Figure 37. United States Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Region in 2021
Figure 42. APAC Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Regions in 2021
Figure 43. China Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country in 2021
Figure 50. Europe Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country in 2021
Figure 51. Germany Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country in 2021
Figure 58. Egypt Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Omalizumab Monoclonal Antibody Biosimilars in 2021
Figure 64. Manufacturing Process Analysis of Omalizumab Monoclonal Antibody Biosimilars
Figure 65. Industry Chain Structure of Omalizumab Monoclonal Antibody Biosimilars
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Omalizumab Monoclonal Antibody Biosimilars
Figure 2. Omalizumab Monoclonal Antibody Biosimilars Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Omalizumab Monoclonal Antibody Biosimilars Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Omalizumab Monoclonal Antibody Biosimilars Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 150 mg/mL
Figure 10. Product Picture of 75 mg/0.5 mL
Figure 11. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Type in 2021
Figure 12. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Type (2017-2022)
Figure 13. Omalizumab Monoclonal Antibody Biosimilars Consumed in Persistent Asthma
Figure 14. Global Omalizumab Monoclonal Antibody Biosimilars Market: Persistent Asthma (2017-2022) & (Units)
Figure 15. Omalizumab Monoclonal Antibody Biosimilars Consumed in Nasal Polyps
Figure 16. Global Omalizumab Monoclonal Antibody Biosimilars Market: Nasal Polyps (2017-2022) & (Units)
Figure 17. Omalizumab Monoclonal Antibody Biosimilars Consumed in Chronic Idiopathic Urticaria
Figure 18. Global Omalizumab Monoclonal Antibody Biosimilars Market: Chronic Idiopathic Urticaria (2017-2022) & (Units)
Figure 19. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Application (2017-2022)
Figure 20. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Application in 2021
Figure 21. Omalizumab Monoclonal Antibody Biosimilars Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Company in 2021
Figure 23. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Geographic Region in 2021
Figure 25. Global Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Region (2017-2022)
Figure 26. Global Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country/Region in 2021
Figure 27. Americas Omalizumab Monoclonal Antibody Biosimilars Sales 2017-2022 (Units)
Figure 28. Americas Omalizumab Monoclonal Antibody Biosimilars Revenue 2017-2022 ($ Millions)
Figure 29. APAC Omalizumab Monoclonal Antibody Biosimilars Sales 2017-2022 (Units)
Figure 30. APAC Omalizumab Monoclonal Antibody Biosimilars Revenue 2017-2022 ($ Millions)
Figure 31. Europe Omalizumab Monoclonal Antibody Biosimilars Sales 2017-2022 (Units)
Figure 32. Europe Omalizumab Monoclonal Antibody Biosimilars Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales 2017-2022 (Units)
Figure 34. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue 2017-2022 ($ Millions)
Figure 35. Americas Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country in 2021
Figure 36. Americas Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country in 2021
Figure 37. United States Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Region in 2021
Figure 42. APAC Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Regions in 2021
Figure 43. China Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country in 2021
Figure 50. Europe Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country in 2021
Figure 51. Germany Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Omalizumab Monoclonal Antibody Biosimilars Revenue Market Share by Country in 2021
Figure 58. Egypt Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Omalizumab Monoclonal Antibody Biosimilars Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Omalizumab Monoclonal Antibody Biosimilars in 2021
Figure 64. Manufacturing Process Analysis of Omalizumab Monoclonal Antibody Biosimilars
Figure 65. Industry Chain Structure of Omalizumab Monoclonal Antibody Biosimilars
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
